Adrenaline Facilitates Synaptic Transmission by Synchronizing Release of Acetylcholine Quanta from Motor Nerve Endings.

Cellular and Molecular Neurobiology
V F Khuzakhmetova, Ellya A Bukharaeva


The long history of studies on the effect of catecholamines on synaptic transmission does not answer the main question about the mechanism of their action on quantal release in the neuromuscular junction. Currently, interest in catecholamines has increased not only because of their widespread use in the clinic for the treatment of cardiovascular and pulmonary diseases but also because of recent data on their possible use for the treatment of certain neurodegenerative diseases, muscle weakness and amyotrophic sclerosis. Nevertheless, the effects and mechanisms of catecholamines on acetylcholine release remain unclear. We investigated the action of noradrenaline and adrenaline on the spontaneous and evoked quantal secretion of acetylcholine in the neuromuscular junction of the rat soleus muscle. Noradrenaline (10 μM) did not change the spontaneous acetylcholine quantal release, the number of released quanta after nerve stimulation, or the timing of the quantal secretion. However, adrenaline at the same concentration increased spontaneous secretion by 40%, increased evoked acetylcholine quantal release by 62%, and synchronized secretion. These effects differ from those previously described by us in the synapses of the frog cutaneo...Continue Reading


May 1, 1971·British Journal of Pharmacology·B L Ginsborg, G D Hirst
Aug 1, 1971·The Journal of Physiology·K Kuba, T Tomita
Dec 1, 1972·The Journal of Physiology·E F Barrett, C F Stevens
Feb 10, 1967·Annals of the New York Academy of Sciences·W C Bowman, C Raper
Jun 8, 1999·The Journal of Physiology·E A BukcharaevaF Vyskocil
Feb 12, 2002·Journal of Pharmaceutical and Biomedical Analysis·S García PalopJ Martínez Calatayud
Aug 17, 2002·Trends in Neurosciences·Jen-Wei Lin, Donald S Faber
Jan 6, 1962·Nature·W C BOWMAN, C RAPER
Feb 16, 1965·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B KATZ, R MILEDI
May 28, 2005·Current Opinion in Neurobiology·Ralf Schneggenburger, Erwin Neher
Nov 23, 2005·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·T Soić-VranićM Nikolić
Jul 18, 1895·The Journal of Physiology·G Oliver, E A Schäfer
Jan 11, 2007·Journal of Neurochemistry·Ellya A BukharaevaLev G Magazanik
Oct 25, 2007·American Journal of Physiology. Endocrinology and Metabolism·David B Bylund
Dec 12, 2012·Neuromuscular Disorders : NMD·Georgina BurkeStephanie Robb
Jul 13, 2013·The International Journal of Biochemistry & Cell Biology·Olivier R JoassardDamien G Freyssenet
Oct 23, 2013·Frontiers in Physiology·Rüdiger RudolfLuiz C C Navegantes
Nov 28, 2013·Annual Review of Physiology·Pascal S Kaeser, Wade G Regehr
Sep 18, 2014·Scandinavian Journal of Medicine & Science in Sports·N DecorteB Wuyam
Mar 21, 2015·Lancet Neurology·Andrew G EngelSteven M Sine
Sep 25, 2015·The Journal of Physiology·Simeon P Cairns, Fabio Borrani
Jan 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·Muzamil Majid KhanRüdiger Rudolf
Feb 7, 2018·Annals of the New York Academy of Sciences·Claire Legay
Jul 4, 2018·International Journal of Molecular Sciences·Tatjana StrakaRüdiger Rudolf
Nov 6, 2018·Frontiers in Cellular Neuroscience·Chao-Hua Huang, Tobias Moser
Feb 15, 2019·Molecular and Cellular Neurosciences·Anna Zaia Carolina RodriguesOsvaldo Delbono

❮ Previous
Next ❯


May 1, 2021·International Journal of Molecular Sciences·Ellya BukharaevaAndrei Tsentsevitsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.